Md Quamar Azam1, Stephen McMahon2, Gabrielle Hawdon3, Sukesh Rao Sankineani4. 1. King Fahd Hospital of the University, University of Dammam, Al-Khobar, 31952, Saudi Arabia. qazam47@gmail.com. 2. Malabar Orthopaedic Institute, The Avenue Hospital, 43, The Avenue, Windsor, Melbourne, 3141, Australia. steve.mcmahon@joint-replacements.com. 3. Malabar Orthopaedic Institute, The Avenue Hospital, 43, The Avenue, Windsor, Melbourne, 3141, Australia. Gabrielle@joint-replacements.com. 4. Malabar Orthopaedic Institute, The Avenue Hospital, 43, The Avenue, Windsor, Melbourne, 3141, Australia. sukeshrao.sankineni@gmail.com.
Abstract
INTRODUCTION: Resurfacing as a percentage of total hip arthroplasty rose from 5.6 % in 2001 to 8.9 % in 2005 in Australia. During the same period the resurfacing to conventional prosthesis rose from 19.6 % to 29 % in the younger age group (less than 55 years). Long term (more than ten years) functional results of BHR are sparingly documented. Among the literatures available, the patient selection criteria vary from osteoarthritis, avascular necrosis, and dysplastic hip to slipped capital femoral epiphysis. The objective of the current study is to evaluate long term survivorship and functional outcome of Birmingham hip resurfacing surgery in osteoarthritic hip patients performed by a single surgeon. PATIENTS AND METHODS: In this retrospective clinical study, all patients who underwent hip resurfacing for osteoarthritis of hip between 1999 and 2004 are included. All surgeries were performed by single surgeon (SJM) and in all patients Smith & Nephew system (Midland Medical Technologies, Birmingham, United Kingdom)) was used. Revision surgery is considered the end point of survivorship. Means, standard deviations, and confidence interval were calculated for all continuous measures. Survival analysis was performed with the Kaplan-Meier method and 95 % confidence intervals were calculated. RESULT: The result is based on 222 patients (244 hips). This included 153 males and 69 females. Our mean follow up was 12.05 years and overall survival was 93.7 %. In terms of gender, survival in males was 95.43 % while in females it was 89.86 %. Failure was seen in 14 patients (16 hips), which included seven female (10.14 %) and seven male (4.57 %) patients. Failure of femoral components due to aseptic loosening and varus collapse was seen in eight patients after a mean 9.6 years. Metal allergy was seen in three patients (five hips), all of them were female of which two had bilateral resurfacing. Other complications included femoral neck stress fractures in two patients and acetabular component loosening in one patient. We observed that the failure rate is higher if the BHR femoral component size is 46 or less (ten out of 16 hips revised). CONCLUSION: If patient selection is judiciously done and surgical technique is meticulously followed, hip resurfacing offers acceptable survivorship, satisfactory range of motion and enables patients to resume high demand activities including sports. Future improvements in the bearing surfaces, and possibly in the design, might alleviate concerns posed by high serum metal level and provide options that continue to benefit younger patients in future.
INTRODUCTION: Resurfacing as a percentage of total hip arthroplasty rose from 5.6 % in 2001 to 8.9 % in 2005 in Australia. During the same period the resurfacing to conventional prosthesis rose from 19.6 % to 29 % in the younger age group (less than 55 years). Long term (more than ten years) functional results of BHR are sparingly documented. Among the literatures available, the patient selection criteria vary from osteoarthritis, avascular necrosis, and dysplastic hip to slipped capital femoral epiphysis. The objective of the current study is to evaluate long term survivorship and functional outcome of Birmingham hip resurfacing surgery in osteoarthritic hippatients performed by a single surgeon. PATIENTS AND METHODS: In this retrospective clinical study, all patients who underwent hip resurfacing for osteoarthritis of hip between 1999 and 2004 are included. All surgeries were performed by single surgeon (SJM) and in all patients Smith & Nephew system (Midland Medical Technologies, Birmingham, United Kingdom)) was used. Revision surgery is considered the end point of survivorship. Means, standard deviations, and confidence interval were calculated for all continuous measures. Survival analysis was performed with the Kaplan-Meier method and 95 % confidence intervals were calculated. RESULT: The result is based on 222 patients (244 hips). This included 153 males and 69 females. Our mean follow up was 12.05 years and overall survival was 93.7 %. In terms of gender, survival in males was 95.43 % while in females it was 89.86 %. Failure was seen in 14 patients (16 hips), which included seven female (10.14 %) and seven male (4.57 %) patients. Failure of femoral components due to aseptic loosening and varus collapse was seen in eight patients after a mean 9.6 years. Metalallergy was seen in three patients (five hips), all of them were female of which two had bilateral resurfacing. Other complications included femoral neck stress fractures in two patients and acetabular component loosening in one patient. We observed that the failure rate is higher if the BHR femoral component size is 46 or less (ten out of 16 hips revised). CONCLUSION: If patient selection is judiciously done and surgical technique is meticulously followed, hip resurfacing offers acceptable survivorship, satisfactory range of motion and enables patients to resume high demand activities including sports. Future improvements in the bearing surfaces, and possibly in the design, might alleviate concerns posed by high serum metal level and provide options that continue to benefit younger patients in future.
Authors: Michael A Mont; Phillip S Ragland; Gracia Etienne; Thorsten M Seyler; Thomas P Schmalzried Journal: J Am Acad Orthop Surg Date: 2006-08 Impact factor: 3.020
Authors: Gulraj S Matharu; Fiona Berryman; Lesley Brash; Paul B Pynsent; Ronan B Treacy; David J Dunlop Journal: Int Orthop Date: 2015-02-06 Impact factor: 3.075
Authors: Donald S Garbuz; Michael Tanzer; Nelson V Greidanus; Bassam A Masri; Clive P Duncan Journal: Clin Orthop Relat Res Date: 2009-08-21 Impact factor: 4.176
Authors: Robert-Tobias Steffen; Pedro R Foguet; Stephen J Krikler; Roger Gundle; David J Beard; David W Murray Journal: J Arthroplasty Date: 2008-06-13 Impact factor: 4.757
Authors: Francesco Pisanu; Carlo Doria; Matteo Andreozzi; Marco Bartoli; Laura Saderi; Giovanni Sotgiu; Paolo Tranquilli Leali Journal: Int Orthop Date: 2018-09-29 Impact factor: 3.075
Authors: Panagiotis K Karampinas; Eustratios G Papadelis; John A Vlamis; Hlias Basiliadis; Spiros G Pneumaticos Journal: Eur J Orthop Surg Traumatol Date: 2017-01-03
Authors: Jonathan Bourget-Murray; Scott J Watt Kearns; Sophie Piroozfar; Jayd Lukenchuk; Kelly Johnston; Jason Werle Journal: Can J Surg Date: 2022-05-03 Impact factor: 2.089
Authors: James Stoney; Stephen E Graves; Richard N de Steiger; Sophia Rainbird; Thu-Lan Kelly; Alesha Hatton Journal: Clin Orthop Relat Res Date: 2020-11 Impact factor: 4.755